VCT logo

Victrex plc Stock Price

LSE:VCT Community·UK£570.1m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author

VCT Share Price Performance

UK£6.55
-4.13 (-38.67%)
UK£7.79
Fair Value
UK£6.55
-4.13 (-38.67%)
15.9% undervalued intrinsic discount
UK£7.79
Fair Value
Price UK£6.55
AnalystConsensusTarget UK£7.79
AnalystLowTarget UK£5.75
AnalystHighTarget UK£11.00

VCT Community Narratives

AnalystConsensusTarget·
Fair Value UK£7.79 15.9% undervalued intrinsic discount

China Plant And Magma Programme Will Expand Market Reach

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AnalystLowTarget·
Fair Value UK£5.75 13.9% overvalued intrinsic discount

Circular Economy Risks Will Overturn Margins While Select Sectors Recover

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value UK£11 40.5% undervalued intrinsic discount

High-performance Polymers Will Drive EV, Aerospace And Medical Expansion

1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
UK£5.75
13.9% overvalued intrinsic discount
Revenue
2.59% p.a.
Profit Margin
15.11%
Future PE
13.07x
Price in 2028
UK£7.17
UK£7.79
15.9% undervalued intrinsic discount
Revenue
4.56% p.a.
Profit Margin
15.11%
Future PE
16.72x
Price in 2028
UK£9.71
UK£11
40.5% undervalued intrinsic discount
Revenue
5.4% p.a.
Profit Margin
21.31%
Future PE
16.05x
Price in 2028
UK£13.69

Trending Discussion

Updated Narratives

VCT logo

VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential

Fair Value: UK£5.75 13.9% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VCT logo

VCT: Future Upside Will Be Driven By Medical Volume Rebound

Fair Value: UK£7.79 15.9% undervalued intrinsic discount
11 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VCT logo

High-performance Polymers Will Drive EV, Aerospace And Medical Expansion

Fair Value: UK£11 40.5% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with acceptable track record.

2 Risks
3 Rewards

Victrex plc Key Details

UK£292.7m

Revenue

UK£163.8m

Cost of Revenue

UK£128.9m

Gross Profit

UK£101.1m

Other Expenses

UK£27.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.32
44.04%
9.50%
9.3%
View Full Analysis

About VCT

Founded
1993
Employees
1169
CEO
Jakob Sigurdsson
WebsiteView website
www.victrexplc.com

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.

Recent VCT News & Updates

Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614

Dec 24
Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614

Recent updates

No updates